Hiromi Wettersten

Title: Hiromi Wettersten: Innovator in Cancer Treatment

Introduction: Hiromi Wettersten is a prominent inventor based in La Jolla, California. She is affiliated with the University of California, where she focuses on groundbreaking research in cancer treatment. Despite having no granted patents, her work is significant in the field of medical innovations.

Latest Patent Applications: Hiromi Wettersten has filed several notable patent applications, including "Compositions and Methods for Targeting and Killing Alpha-V Beta-3-Positive Cancer Stem Cells (CSCs) and Treating Drug Resistant Cancers." This application provides compositions and methods for treating or ameliorating cancer by targeting cell surface-expressed αvβ3 polypeptides in Cancer Stem Cells (CSCs). The goal is to kill the CSCs, thereby treating or slowing the development of cancers sustained by these cells. Another application, "Compositions and Methods for Targeting and Killing Alpha-V Beta-3-Positive Cancer Stem Cells (CSCs) and Treating Drug Resistant and Metastatic Cancers," focuses on advanced cancers that express αvβ3 polypeptides. It utilizes human or humanized antibodies capable of binding to these polypeptides, inducing an antibody-dependent cell-mediated cytotoxicity (ADCC) reaction against cancer cells.

Conclusion: Hiromi Wettersten's innovative research and patent applications represent a significant contribution to the fight against cancer. Her work aims to develop effective treatments for drug-resistant and metastatic cancers, showcasing her dedication to advancing medical science.